Conditions: Triple-Negative Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Head and Neck Carcinoma, Squamous Cell; Advanced Solid Tumors
Interventions: Drug: TAK-659; Drug: Nivolumab
Sponsor: Millennium Pharmaceuticals, Inc.
Not yet recruiting - verified July 2016
from #ORL via xlomafota13 on Inoreader http://ift.tt/29VoQNh
via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου